Purchases and Sales Made in Q4 2024 in Charles River Laboratories International, Inc. (CRL)
This table provides information about the institutional ownership of Charles River Laboratories International, Inc. (CRL) during Q4 2024. The information is specifically focused on institutions that hold shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jun 30, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-179K- 43.49% |
$32M - $39.5M
|
232K
$36.7M
|
|
Feb 06, 2025
Q4 2024
|
Woodley Farra Manion Portfolio Management Inc
|
SELL
|
- |
-233K- 98.91% |
$41.5M - $51.3M
|
2.56K
$405K
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-287K- 93.01% |
$51.3M - $63.4M
|
21.6K
$3.41M
|
|
Feb 12, 2025
Q4 2024
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-316K- 28.94% |
$56.4M - $69.7M
|
775K
$123M
|
|
Feb 10, 2025
Q4 2024
|
Thrivent Financial For Lutherans
Minneapolis, MN |
SELL
|
- |
-327K- 98.37% |
$58.4M - $72.2M
|
5.42K
$857K
|
|
Feb 14, 2025
Q4 2024
|
Eminence Capital, LP
New York, NY |
SELL
|
- |
-376K- 37.47% |
$67.1M - $83M
|
627K
$99.2M
|
|
Jan 30, 2025
Q4 2024
|
Congress Asset Management CO
|
SELL
|
- |
-430K- 98.99% |
$76.7M - $94.8M
|
4.36K
$689K
|